Giuseppe Ciaramella, Ph.D.

Giuseppe Ciaramella, Ph.D.

PresidentatBeam Therapeutics· In proxies 2021–2025

Pay in FY2025-6% from the year before · Beam Therapeutics stock +11.8% the same year

Giuseppe Ciaramella, Ph.D. was paid $3.2M in FY2025 (Dec), down 6%. Beam Therapeutics stock rose 11.8% that year.

Pay$100 in the stock at the end of FY20 → $34
Pay is from the Summary Compensation Table of each Beam Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Beam TherapeuticsPublic company · 5 yr
    • President2021 – Present · 5 yrStock in role -67%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?